簡易檢索 / 詳目顯示

研究生: 蘇美欣
Su, Mei-Hsin
論文名稱: 在大白鼠血漿中amisulpride鏡像異構物的高效液相層析法及毛細管電泳定量方法之開發與應用
Enantioselective quantification of amisulpride in small volumes of rat plasma by HPLC and capillary electrophoresis: method development and application
指導教授: 周辰熹
Chou, Chen-Hsi
學位類別: 碩士
Master
系所名稱: 醫學院 - 臨床藥學研究所
Institute of Clinical Pharmacy
論文出版年: 2007
畢業學年度: 95
語文別: 中文
論文頁數: 85
中文關鍵詞: 對掌性分離作用高效液相層析法毛細管電泳法β-cyclodextrin衍生物立體選擇性作用
外文關鍵詞: modified β-cyclodextrin derivatives, Amisulpride, enantioselective, chiral separation, high-performance liquid chromatography, capillary electrophoresis
相關次數: 點閱:161下載:5
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 許多已上市藥品具有鏡像異構物,但臨床使用上卻是外消旋化物(racemate),也就是以兩個鏡像異構物50:50比例混合之混合物。而這兩個化學結構相似的鏡像異構物卻常有著不同的藥效與藥動性質。一般用於消旋化物的藥物定量方法,因為無法分析出鏡像異構物的差異,可能造成在探討鏡像異構物的藥物動態訊息上,有嚴重的影響及損失。Amisulpride屬於非典型的抗精神病藥物,且具有兩個鏡像異構物。而相關研究顯示S(-)amisulpride較R(+)amisulpride具有主要的藥理活性。然而在探討amisulpride鏡像異構物方面,由於相關分析方法十分缺乏,且大部分的amisulpride的定量方法主要是運用在藥物製劑上,很少有針對生物檢體上的應用,故影響到有關amisulpride鏡像異構物藥物動力學之探討。
    因此本研究目的在於開發並確效兼具靈敏、對掌性的及可定量amisulpride鏡像異構物於小體積之大白鼠血漿中濃度的高效液相層析法與毛細管電泳法 ; 並將所開發之方法應用在偵測amisulpride
    鏡像異構物在大白鼠體內之濃度。
    實驗結果已成功的開發了三種amisulpride之分析方法,分別是運用螢光偵測的非對掌性高效液相層析法、使用經修β-cyclodextrin衍生物作為對掌試劑與搭配螢光偵測之對掌性高效液相層析法及同樣使用經修飾β-cyclodextrin衍生物作為對掌試劑與搭配光電二極體偵測器偵測的毛細管電泳法。其中,非對掌性高效液相層析法與對掌性毛細管電泳法運用在小體積之大白鼠血漿中amisulpride濃度之偵測經過完整的確效評估。此外,並以具對掌性毛細管電泳法運用來偵測大白鼠體內amisulpride鏡像異構物之濃度。自靜脈注射給予大白鼠amisulpride的實驗中顯示,amisulpride鏡像異構物在大白鼠體內具有類似的濃度及藥品動態。而在離體肝臟灌流amisulpride的實驗中顯示,amisulpride鏡像異構物在大白鼠膽汁中具有立體選擇性的差異。其中S(-)amisulpride的濃度大於 R(+)amisulpride且具有統計學上之差異,這也暗示了藥物運輸子(例如P-gp)之於amisulpride或許具有立體選擇性之差異。
    整體而言,本研究成功的開發了三個可以偵測於小體積之大白鼠血漿中amisulpride及其鏡像異構物的高效液相層析法與毛細管電泳法。此外並成功的運用在偵測大白鼠體內amisulpride鏡像異構物的藥品濃度,此外並發現amisulpride在膽汁中具有主動且立體選擇性的排除作用。然而,關於amisulpride鏡像異構物的藥動機制仍需做近ㄧ步研究才可以釐清。

    Introduction:Many drugs are marketed as racemic mixtures, although the individual enantiomers frequently differ in both their pharmacodynamic and pharmacokinetic profiles. The importance of stereochemistry and hence the need for enantioselective analytical methods has long been recognized especially in pharmacokinetic studies. Amisulpride((±)-4-amino- N-[(1-ethyl- 2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide) is an atypical antipsychotic drug that has two enantiomers. In vitro binding studies show that S(-)amisulpride owns the major pharmacologic activities than R(+)amisulpride. However, only a few studies have investigated the chiral separation of amisulpride. Most of the analytical methods of amisulpride are for the application in pharmaceuticals, and not for the quantification of amisulpride enantiomers in biological fluids. For these reasons, pharmacokinetic studies of enantiomers of amisulpride are limited.

    Purpose: The aim of this study was to develop and validate sensitive and enantioselective high-performance liquid chromatographic (HPLC) method and capillary electrophoretic (CE) method for the analysis of amisulpride in small volumes of rat plasma, and to apply the methods to characterize the kinetics of amisulpride enantionmers in rats.

    Results: Three new sensitive analytical methods for amisulpride were developed, including an achiral HPLC method with fluorescence detection, a chiral HPLC method with fluorescence detection using modified β-cyclodextrin derivative as the chiral selector, and a chiral CE method with photo-diarry detection using modified β-cyclodextrin derivative as the chiral selector. The achiral HPLC method and the chiral CE method were validated for the determination of amisulpride in small volumes of rat plasma. The chiral CE method was applied to pharmacokinetic studies of amisulpride in rats. It was shown that the disposition kinetics of amisulpride enatiomers following bolus injection of amisulpride to rats were similar. However, active biliary secretion of amisulpride was found in the isolated perfused rat liver. Furthermore, as S(-)amisulpride has higher biliary concentration than R(+)amisulpride, the secretion appeared to be enantioselective.

    Conclusion. In summary, three new sensitive HPLC and CE methods were developed and validated for the determination of amisulpride and its enantiomers in biological fluids. The CE method was applied successfully to characterize the disposition kinetics and the active and enantioselective biliary secretion of enatiomers of amisulpride in rats.

    摘要.........................................Ⅰ Abstract................................... III 誌謝..........................................V 表目錄........................................X 圖目錄………………………………………………………………XI 縮寫表 …………………………………XIV 第壹章 緒論...................................1 第一節 對掌性藥品動態學…………………………………………….1 一、簡介…………………………………………………………………1 二、對掌性藥物分析方法之開發………………………………………1 第二節 Amisulpride簡介………………………………………………2 一、物化特性……………………………………………………………2 二、藥理作用……………………………………………………………3 三、藥動性質……………………………………………………………3 四、Amisulpride鏡像異構物藥理特性……………………………..4 五、Amisulpride鏡像異構物藥動特性………………………………5 第三節 Amisulpride分析方法之文獻回顧………………………….6 第四節 環糊精 ( cyclodextrins ; CDs ) …………………………8 一、基本性質………………………………………………….......8 二、分旋作用機制…………………………………….............9 三、結合型態………………………………………….............9 第五節 分旋參數計算………………………………………………..10 一、高效液相層析模式……………………………………………….10 二、毛細管電泳模式………………………………………………….11 第六節 毛細管電泳介紹………………………………………………12 一、發展簡介………………………………………………………..12 二、儀器裝置………………………………………………………..12 三、分離原理………………………………………………………..13 第貳章 研究目的………………………………………………………18 第一節 Amisulpride定量分析方法開發與確效…………………….18 第二節 Amisulpride鏡像異構物在大白鼠體內濃度之探討……….19 第參章 實驗材料、儀器及方法………………………………………20 第一節 實驗材料…………………………………………………...20 一、實驗動物………………………………………………………..20 二、藥品與試劑……………………………………………………..20 第二節 實驗儀器…………………………………………………...21 一、紫外可見光分光光度計……………………………………….21 二、螢光分光光度計……………………………………………….21 三、高效液相層析系統…………………………………………….21 四、毛細管電泳系統……………………………………………….22 五、靜脈插管手術………………………………………………….22 六、肝臟灌流系統………………………………………………….23 七、繪圖及藥動分析軟體 ………………………………………...24 第三節 實驗方法…………………………………………………...24 一、藥品配製……………………………………………………….24 二、紫外光與螢光光譜掃描……………………………………….25 三、分析方法最適化……………………………………………….25 四、Amisulpride 生物檢體製備…………………………………...27 五、Amisulpride 生物檢體定量分析……………………………...29 六、Amisulpride 鏡像異構物在大白鼠體內濃度之探討…………31 第肆章 實驗結果………………………………………………………32 第一節 紫外光與螢光光譜……………………………………………32 一、pH值之影響…………………………………………………32 二、Modified β-cyclodextrin derivative之影響………….34 第二節 非對掌性高效液相層析法之開發與確效……………………40 一、分析條件最適化……………………………………………...40 二、分析方法之確效……………………………………………..40 第三節 對掌性高效液相層析法之開發………………………………45 一、分析條件最適化…………………………………………………45 第四節 對掌性毛細管電泳法之開發與確效…………………………54 一、分析條件最適化 ………………………………………………54 二、分析方法之確效………………………………………………….60 第五節 Amisulpride鏡像異構物在大白鼠體內濃度之探討.....67 一、靜脈注射實驗 …………………………………………………67 二、肝臟離體灌流實驗…………………………………….68 第伍章 討論............................................70 第一節 紫外光與螢光光譜掃描 ...........................70 一、pH值之影響...................................70 二、Modified β-cyclodextrin derivative之影響………………70 第二節 非對掌性高效液相層析法之開發與確效................71 一、分析條件最適化......................................71 二、分析方法之確效………………………………………………….71 第三節 對掌性高效液相層析法之開發………………………………72 一、分析條件最適化…………………………………………….72 第四節 對掌性毛細管電泳法之開發與確效……………………….74 一、分析條件最適化………………………………………………...74 二、分析方法之確效…………………...……………………………77 第五節 Amisulpride鏡像異構物在大白鼠體內濃度之探討 …78 一、靜脈注射實驗 ………………………………………………….78 二、肝臟離體灌流實驗 ………………………………….78 第陸章 結論……………………………………………………………80 參考文獻……………………………………………………………..81 自述…………………………………………………………………..85

    Ascalone V, Ripamonti M and Malavasi B (1996) Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid-phase extraction and liquid chromatography on a chiral column. application to pharmacokinetics. J Chromatogr B 676:95-105.

    Asztemborska M, Bielejewska A, Duszczyk K and Sybilska D (2000) Comparative study on camphor enantiomers behavior under the conditions of gas–liquid chromatography and reversed-phase high-performance liquid chromatography systems modified with a- and β-cyclodextrins. Journal of Chromatography A 874:73-80.

    Beckman Instrument ,Inc.(1994) Introduction to CapillaryElectrophoresis, Beckman Coulter ,U.S.A

    Bohbot M. , Doare L. and Diquet B. (1987) Determination of a new benzamide , amisulpride , in human plasma by reversed-phase ion-pair high-performance liquid chromatography . Journal of Chromatography 416 : 414-419

    Brocks DR (2006) Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharm Drug Dispos 27:387-406.

    Castelli MP, Mocci I, Sanna AM, Gessa GL and Pani L (2001) (-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors. Eur J Pharmacol 432:143-147.

    Coukell AJS, Caroline M.; Benfield, Paul (1996) Amisulpride: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia CNS Drugs 6:237-256.

    Gschwend MH, Arnold P, Ring J and Martin W (2006) Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. J Chromatogr B 831:132-139.

    Hefnawy MM, Sultan MA and Al-Shehri MM (2007) Enantioanalysis of bisoprolol in human plasma with a macrocyclic antibiotic HPLC chiral column using fluorescence detection and solid phase extraction. Chem Pharm Bull (Tokyo) 55:227-230.

    Kuhn R and Hofstetter-Kuhn S(1993)Capillary electrophoresis :principles and practice. Springer-Verlag,New York

    Le Bricon C,Hulot T,Canal M,Hortan N, Lins RL(1996)Pharmacokinetics of amisulpride and its enantiomers after single and repeated doses in healthy volunteers (special issue). Eur J Drug Metab Pharmacokinet 135-136.

    Loftsson T and Brewster ME (1996) Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.

    Loftsson T and Duchene D(2007) Cyclodextrins and theirpharmaceutical applications. Int J Pharm 329:1-11.

    Marchese G, Bartholini F, Ruiu S, Casti P, Saba P, Gessa G and Pani L (2002a) Effect of the amisulpride isomers on rat catalepsy. Eur J Pharmacol 444:69-74.

    Marchese G, Ruiu S, Casti P, Saba P, Gessa GL and Pani L (2002b) Effect of the amisulpride isomers on rat prolactinemia. Eur J Pharmacol 448:263-266.

    Malavasi B, Locatelli M, Ripamonti M and Ascalone V (1996) Determination of amisulpride, a new benzamide derivative, in human plasma and urine by liquid-liquid extraction or solid-phase extraction in combination with high-performance liquid chromatography and fluorescence detection. application to pharmacokinetics. J Chromatogr B Biomed Appl 676:107-115.

    Martinez-Gomez MA, Sagrado S, Villanueva-Camanas RM and Medina-Hernandez MJ (2007) Enantiomeric quality control of antihistamines in pharmaceuticals by affinity electrokinetic chromatography with human serum albumin as chiral selector. Anal Chim Acta 592:202-209.

    Musenga A, Mandrioli R, Morganti E, Fanali S and Raggi MA (2007) Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresis. J Pharm Biomed Anal.(in press)

    Nishi H and Kuwahara Y (2001) Enantiomer separation by capillary electrophoresis utilizing noncyclic mono-, oligo- and polysaccharides as chiral selectors. J Biochem Biophys Methods 48:89-102.

    O'Neil, Maryadele J (2001)The Merck index :an encyclopedia of chemicals, drugs, and biologicals , Merck Research Laboratories, Whitehouse Station

    Pehourcq FO, S. Begaud, B. (2003) Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication. J Chromatogr B 789:101-105.

    Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I and Bianchetti G (2002) A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol 17:1-13.

    Schmitt U, Abou El-Ela A, Guo LJ, Glavinas H, Krajcsi P, Baron JM, Tillmann C, Hiemke C, Langguth P and Hartter S (2006) Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). J Neural Transm 113:787-801.

    Schneiderman E and Stalcup AM (2000) Cyclodextrins: a versatile tool in separation science. J Chromatogr B 745:83-102.

    Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J and Scatton B (1997) Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity J Pharmacol Exp Ther 280(1):83-97.

    Sewell P.A.,Kealey D. and Clarke Brian (1987) Chromatographic separations.A.Thames Polytechnic,London by J.Wiley,Chichester, New York

    Shuang S and Choi M (2001) Retention behaviour and fluorimetric detection of procaine hydrochloride using carboxymethy - beta -
    cyclodextrin as an additive in reversed-phaseliquid chromatography J Chromatogr A 919:321-329.

    Silvio C (2000) Biotransformation of post-clozapine antipsychotics. Clin Pharmacokinet 38:393-414.

    Skibinski R, Komsta L, Hopkala H and Suchodolska I (2007) Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods. Anal Chim Acta 590:195-202.

    Sokoloff P AM, Besancon R, Pilon C, Martres MP, Giros B, Schwartz JC (1992) harmacology of human dopamine D3 receptor expressed in a mammalian cell line:comparison with D2 receptor. Eur J Pharmacol 10:331-337.

    康桂禎(2006)用高效液相層析搭配螢光偵測器以研究Vardenafil在大白鼠堤內的藥物動力學, 國立成功大學臨床藥學所93級碩士論文p33-34

    傅嘉宏(2004)溫感性生物可分解之高分子聚合物於藥物傳釋及輸送之研究 , 國立成功大學臨床藥學所91級碩士論文

    下載圖示 校內:2022-08-30公開
    校外:2022-08-30公開
    QR CODE